ArticleEClinicalMedicine2026

Long-term efficacy and safety of Control-IQ technology in younger children with type 1 diabetes in Italy (2020-2023): a longitudinal multicentre real-world study.

Valentino Cherubini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.